Ftse Mib
34.271,12
-0,27%
DAX
18.077,71
-0,36%
S&P 500
5.071,63
0,02%
NASDAQ Composite
15.712,75
0,10%
Bitcoin
64.217,96
-0,10%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistente personale
Home Investire Azioni U.S.A. AMEX iBio Inc (IBIO) iBio Inc (IBIO) Notizie

iBio Inc

IBIO
1,8513
-0,0487 (-2,56%)
24 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/3/202412:00GLOBEiBio and AstralBio Announce Transformative AI drug discovery..
27/3/202400:35GLOBEiBio Announces $15.0 Million Private Placement
26/2/202413:59EDGAR2Form 8-K - Current report
26/2/202413:45GLOBEiBio Announces Sale of Preclinical PD-1 Agonist Antibody..
21/2/202422:55EDGAR2Form 8-K - Current report
19/1/202422:36EDGAR2Form 8-K - Current report
16/1/202414:15GLOBEiBio Announces Participation in 23rd Annual PepTalk..
10/1/202419:24EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202422:30EDGAR2Form 8-K - Current report
04/1/202414:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/12/202313:44EDGAR2Form 8-K - Current report
26/12/202313:15GLOBEiBio Amends and Extends Maturity of Credit Agreement
08/12/202322:17EDGAR2Form 8-K - Current report
06/12/202315:13EDGAR2Form 8-K - Current report
06/12/202314:59EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/12/202314:00GLOBEiBio, Inc. Announces Pricing of $4.5 Million Public Offering
05/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
30/11/202314:55EDGAR2Form S-1/A - General form for registration of securities..
28/11/202314:36EDGAR2Form 8-K - Current report
27/11/202323:20GLOBEiBio Announces Reverse Stock Split
03/11/202321:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202313:24GLOBEiBio Further Expands Tech Stack with ShieldTx™; Enhances..
27/10/202322:29EDGAR2Form S-1 - General form for registration of securities under..
26/10/202314:20EDGAR2Form DEF 14A - Other definitive proxy statements
16/10/202322:59EDGAR2Form PRE 14A - Other preliminary proxy statements
10/10/202314:56EDGAR2Form 8-K - Current report
10/10/202314:00GLOBEiBio to Highlight Technology for Advancing Discovery of..
05/10/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:34EDGAR2Form 8-K - Current report
02/10/202312:45GLOBEiBio Explains Recent Filing of Registration Statement
29/9/202323:28EDGAR2Form POS AM - Post-Effective amendments for registration..
27/9/202322:31EDGAR2Form 8-K - Current report
27/9/202322:19GLOBEiBio Announces Filing of 2023 Annual Report on SEC Form 10-K
27/9/202322:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/9/202322:05GLOBEiBio Announces Amendment to Credit Agreement with Woodforest
21/9/202314:00EDGAR2Form 8-K - Current report
30/8/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:15GLOBEiBio Reports Triple Milestone: In Vivo Proof-of-Concept for..
14/8/202321:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/8/202322:01EDGAR2Form 8-K - Current report
07/8/202315:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/8/202322:47EDGAR2Form 8-K - Current report
28/7/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202314:29EDGAR2Form 8-K - Current report
27/6/202314:00GLOBEiBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO..
12/6/202322:15GLOBEiBio Forges Research Collaboration with the National..
Apertura: 1,98 Min: 1,8302 Max: 1,98
Chiusura: 1,90

La tua Cronologia

AMEX
IBIO
iBio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network